Brief: Herantis granted almost EUR 3 million government loan for Parkinson study
30/06/2015 08:00
June 30 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* Finnish Funding Agency for Innovation, has granted a 2,903,000 euros ($3.20 million) loan
to Herantis to support its clinical study of CDNF (Cerebral Dopamine Neurotrophic Factor) for
the treatment of Parkinson's disease
* Herantis aims to start its clinical development program with regulatory submissions in
Finland and Sweden by end of 2015
* Loan was granted conditionally subject to obtaining regulatory approval for clinical study
Source text for Eikon: ID:nHUG4wz6v
Further company coverage: HRTIS.HE
($1 = 0.8958 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))